Oliver Luxxe Assets LLC Purchases 2,900 Shares of Encompass Health Co. (NYSE:EHC)

Oliver Luxxe Assets LLC lifted its position in Encompass Health Co. (NYSE:EHC) by 4.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,453 shares of the company’s stock after acquiring an additional 2,900 shares during the period. Encompass Health accounts for about 1.0% of Oliver Luxxe Assets LLC’s investment portfolio, making the stock its 26th largest holding. Oliver Luxxe Assets LLC owned about 0.06% of Encompass Health worth $5,860,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in EHC. UMB Bank n.a. grew its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the period. Avior Wealth Management LLC bought a new stake in Encompass Health in the 3rd quarter worth approximately $40,000. Benjamin F. Edwards & Company Inc. increased its position in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Encompass Health in the 2nd quarter worth approximately $58,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on EHC. Truist Financial reissued a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Barclays boosted their price objective on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Finally, KeyCorp lifted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $107.11.

Encompass Health Price Performance

Shares of EHC traded up $0.10 during mid-day trading on Monday, hitting $91.28. 361,439 shares of the company were exchanged, compared to its average volume of 546,428. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health Co. has a 1-year low of $67.12 and a 1-year high of $104.55. The stock has a market cap of $9.20 billion, a price-to-earnings ratio of 22.05, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The company has a 50 day moving average of $98.90 and a 200-day moving average of $93.53.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the business posted $0.86 earnings per share. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. Analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.74%. Encompass Health’s dividend payout ratio is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.